Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Genetic Diseases
4.2.2 Increasing Number of Organ Transplantation
4.2.3 Rising Government Initiatives Related to Advanced Diagnostics
4.3 Market Restraints
4.3.1 Small Size of Study Population and Ethical Concern
4.3.2 Stringent Regulatory Framework
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product and Service
5.1.1 Instruments
5.1.2 Reagents and Consumables
5.1.3 Softwares and Services
5.2 By Application
5.2.1 Diagnosis
5.2.2 Research
5.3 By End User
5.3.1 Hospitals
5.3.2 Research Laboratories
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Beckton, Dickinson and Company
6.1.2 Bio-Rad Laboratories Inc.
6.1.3 F. HOFFMAN-LA ROCHE LIMITED
6.1.4 GenDX
6.1.5 Illumina Inc.
6.1.6 Omixon Inc.
6.1.7 Qiagen
6.1.8 Takara Bio Inc.
6.1.9 TBG Diagnostics Ltd
6.1.10 Thermofisher Scientific Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS